IL-22缺陷增强黏膜免疫接种的CD4 T细胞应答
本研究探讨IL-22在黏膜免疫中对T细胞应答的作用。与野生型对照小鼠相比,IL-22缺陷小鼠经直肠免疫(蛋白抗原加霍乱毒素佐剂疫苗)后抗原特异性CD4 T细胞应答增加;而经铝佐剂全身免疫时,两组CD4 T细胞应答未检测到差异。结果提示黏膜疫苗接种期间短暂抑制IL-22可能增强T细胞应答。
要点
- IL-22缺陷小鼠经直肠免疫后抗原特异性CD4 T细胞应答较野生型对照小鼠增加。
- 经铝佐剂全身免疫时,野生型与IL-22缺陷小鼠的CD4 T细胞应答未检测到差异。
- 作者提示黏膜疫苗接种期间短暂抑制IL-22可能增强T细胞应答。
核心结论
- IL-22缺陷小鼠经直肠免疫后抗原特异性CD4 T细胞应答较野生型对照小鼠增加,而全身免疫时两组未检测到差异,提示黏膜疫苗接种期间短暂抑制IL-22可能增强T细胞应答。
研究设计与样本
- 研究比较野生型对照小鼠与IL-22缺陷小鼠对同一蛋白抗原经直肠免疫(蛋白加霍乱毒素佐剂疫苗)和经铝佐剂全身免疫的CD4 T细胞应答。
主要发现
- 与野生型对照小鼠相比,IL-22缺陷小鼠经直肠免疫后抗原特异性CD4 T细胞应答增加。
- 经铝佐剂全身免疫时,野生型与IL-22缺陷小鼠的CD4 T细胞应答未检测到差异。
临床怎么用
- 作者认为,黏膜疫苗接种期间短暂抑制IL-22可能增强T细胞应答,该思路可能广泛适用于改进现有黏膜疫苗方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mucosal vaccines are a promising platform for combatting infectious diseases for which we still lack effective preventative measures. Optimizing these vaccines to generate the best protective immune responses with the least complicated immunization regimen is imperative. Mucosal barriers are the first line of defense against many pathogens and, as such, we looked to their biology for strategies to improve vaccine delivery. Interleukin-22 (IL-22) is a key cytokine in both healthy and inflamed mucosal tissues. IL-22 promotes epithelial cell proliferation and inhibits apoptosis, upregulates mucin and antimicrobial peptides, all of which promote mucosal barrier integrity. In this study, we find that IL-22 impairs the development of a T cell response during mucosal immunization. Compared to wild-type control mice, IL-22 deficient mice had increased antigen-specific CD4 T cell responses to intrarectal immunization using a protein and cholera toxin adjuvant vaccine. When immunized systemically with the same protein antigen adsorbed to alum, no differences in the CD4 T cell response between wild-type and IL-22 deficient mice were detected. This suggests that transiently inhibiting IL-22 during mucosal vaccination could enhance T cell responses. The broad-applicability of this proposed approach would allow for improvement of many existing mucosal vaccine regimens and have positive implications in the development of more efficacious mucosal vaccines.
引用
- Budda SA, Zenewicz LA. IL-22 deficiency increases CD4 T cell responses to mucosal immunization. Vaccine. 2018. PMID: 29739717. doi:10.1016/j.vaccine.2018.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。